Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic…
5,280$
3,13%
Echtzeit-Aktienkurs Codexis Inc.
Bid:
Ask:
Nachrichten zur Codexis Inc. Aktie
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions…
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic…
Codexis, Inc. 2024 Q3 - Results - Earnings Call Presentation
…
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript
…
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic…
Codexis to Report Third Quarter 2024 Financial Results on October 31
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic…
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., Aug. 16, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis, Inc. (CDXS) Q2 2024 Earnings Call Transcript
…
Codexis to Participate in Jefferies Global Healthcare Conference
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript
…
Codexis, Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Codexis to Report First Quarter 2024 Financial Results on May 2
REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis, Inc. (CDXS) Q4 2023 Earnings Call Transcript
…
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche
REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing
REDWOOD CITY, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023
REDWOOD CITY, Calif., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Codexis, Inc.; Urges Codexis Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
Abbott Cooper PLLC Announces Investigation into Codexis, Inc.…
Codexis, Inc. 2023 Q3 - Results - Earnings Call Presentation
…
Codexis, Inc. (CDXS) Q3 2023 Earnings Call Transcript
…
Codexis to Participate in Upcoming Healthcare Conferences
REDWOOD CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
REDWOOD CITY, Calif., Oct. 27, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis to Participate in Cantor Global Healthcare Conference
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis (CDXS) Reports Q2 Loss, Lags Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of 19.05% and 0.84%, respectively, for the quarter ended June 2023. Do the…
Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics
New Film Highlights Company Commitment to Transforming RNAi Therapeutics Landscape New Film Highlights Company Commitment to Transforming RNAi Therapeutics Landscape...…
Codexis streamlining operations, reducing headcount
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K CODEXIS, INC. For: Jul 20
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K CODEXIS, INC. For: Jun 13
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis (CDXS) Reports Q1 Loss, Lags Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the…
Codexis to Report First Quarter 2023 Financial Results on May 4
REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA
REDWOOD CITY, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Codexis Announces New Employment Inducement Grants
REDWOOD CITY, Calif., April 06, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Form 8-K CODEXIS, INC. For: Mar 29
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors
REDWOOD CITY, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,…
Insiderhandel: Aufsichtsrat verkauft Aktien von Codexis im Wert von 146.681$
Nicols, John J. - Aufsichtsrat - Tag der Transaktion: 2023-03-16...…
Insiderhandel: Aufsichtsrat verkauft Aktien von Codexis im Wert von 146.131$
Nicols, John J. - Aufsichtsrat - Tag der Transaktion: 2023-03-15...…
Insiderhandel: Chief Operating Officer verkauft Aktien von Codexis im Wert von 37.617$
Norrett, Kevin - Vorstand - Tag der Transaktion: 2023-03-08...…
Insiderhandel: Vorstand verkauft Aktien von Codexis im Wert von 36.822$
Fitzgerald, Margaret Nell - Vorstand - Tag der Transaktion: 2023-03-07...…
Insiderhandel: Vorstand verkauft Aktien von Codexis im Wert von 35.011$
Fitzgerald, Margaret Nell - Vorstand - Tag der Transaktion: 2023-03-08...…
Insiderhandel: Vorstand verkauft Aktien von Codexis im Wert von 122.931$
Dilly, Stephen George - Vorstand - Tag der Transaktion: 2023-03-08...…
Insiderhandel: Chief Operating Officer verkauft Aktien von Codexis im Wert von 39.565$
Norrett, Kevin - Vorstand - Tag der Transaktion: 2023-03-07...…
Insiderhandel: Vorstand verkauft Aktien von Codexis im Wert von 129.281$
Dilly, Stephen George - Vorstand - Tag der Transaktion: 2023-03-07...…
Form 10-K CODEXIS, INC. For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of 17.39% and 4.30%, respectively, for the quarter ended December 2022. Do the…